Financials
Financial year 2025
DIEUSAERT MEDICAL PRODUCTS & LOGISTICS from Rotselaar, company number BE0432384824, closed financial year 2025 with a result of € -28,389 after tax. For that financial year DIEUSAERT MEDICAL PRODUCTS & LOGISTICS recorded a gross margin of € 212,127 and equity of € 968,366. Compared with financial year 2024, the result moved from € 14,984 to € -28,389. The company made a loss. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 30, 2026.
€ 968,366
▼ 3% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -28,389
▼ still € 14,984 profit in 2024
Profit after tax over the fiscal year.
€ 601,308
▲ 12% vs 2024
Cash and bank balances on the last day of the fiscal year.
Loss, nothing to pay out
Reserves fell to € 650,366.
People and assets in 2025
€ 197,790
▲ 4% vs 2024
Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 119,840
▲ € 95,295 vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 34,409
▼ 18% vs 2024
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Revenue | € 1,084,129 | € 931,236 | - | - | |
| Gross margin | € 193,434 | € 177,387 | € 233,078 | € 212,127 | ▼ 9% |
| Profit after taxes | € 2,214 | € -7,094 | € 14,984 | € -28,389 | ▼ € 43,374 |
| Equity | € 988,865 | € 981,771 | € 996,755 | € 968,366 | ▼ 3% |
| Total debts | € 257,333 | € 243,520 | € 89,679 | € 175,534 | ▲ 96% |
| Cash | € 520,931 | € 460,606 | € 537,363 | € 601,308 | ▲ 12% |
| Land & buildings | € 50,816 | € 55,968 | € 52,656 | € 52,586 | |
| Retained profit | € 670,865 | € 663,771 | € 678,755 | € 650,366 | ▼ 4% |
| Bank debt | € 35,624 | € 18,615 | € 1,439 | € 0 | ▼ 100% |
| Balance sheet total | € 1,309,237 | € 1,225,291 | € 1,086,434 | € 1,143,900 | ▲ 5% |
| Employees (FTE) | 2.8 | 2.8 | 2.9 | - |
Key figures of DIEUSAERT MEDICAL PRODUCTS & LOGISTICS, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 30 June 2027.
What happened to DIEUSAERT MEDICAL PRODUCTS & LOGISTICS?
What happened at DIEUSAERT MEDICAL PRODUCTS & LOGISTICS in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- Saskia Vranken stepped down as director. NBB
- Belief Investments stepped down as director. NBB
- New annual accounts for financial year 2025: loss of € 28,389 (▼ € 43,374 vs 2024). Source: NBB ↗
- Saskia Vranken became a director. NBB
- Belief Investments became a director. NBB
- New establishment in Rotselaar. KBO
- Start of the company according to the CBE. KBO
In short
From € 2,214 profit in 2022 to € 28,389 loss in 2025.
Paid € 6,913 in corporate taxes since 2022.
Best year ever: 2024, with € 14,984 profit.
On average € 80,400 of value added per employee in 2024.
A new publication or filing at DIEUSAERT MEDICAL PRODUCTS & LOGISTICS? We notify you, reason included.
Follow DIEUSAERT MEDICAL PRODUCTS & LOGISTICSDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
The stake of BELIEF INVESTMENTS comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.
DIEUSAERT MEDICAL PRODUCTS & LOGISTICSThe shares are held by BELIEF INVESTMENTS (100%).
Directors
According to the 2025 annual accounts
Saskia Vranken
Director
Also active at: BELIEF INVESTMENTS, DV Ventures, PRS Pressure Relief Systems Medical
since 2023 · until 2029
Director · represented by Bjorn Dieusaert
Also active at: PRS Pressure Relief Systems Medical
since 2023 · until 2029
Shareholders
100%
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Wingepark 53
3110 Rotselaar
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Website
Technologies
Hosting & Email
Email provider
Outlook.com (free)
Hosting
GOOGLE-CLOUD-PLATFORM - Google LLC, US
Domain
Domain
dmlnv.eu
Registrar
HostYou BV
Website info
Features
Security
Details
- Company number
- 0432.384.824
- VAT number
- BE 0432.384.824
- Registered office
- Wingepark 53, 3110 Rotselaar
- Names & denominations
- DIEUSAERT MEDICAL PRODUCTS & LOGISTICS · D.M.L.
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 6 November 1987
- Peppol
- Active · Active since 10 Oct 2025
- Contact
- dmlnv.eu +32 (0)16 44 01 45
- Activities · NACE
Groothandel in huishoudtextiel en beddengoed
Groothandel in textiel